DZ Bank’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,496
Closed -$171K 799
2018
Q4
$171K Sell
1,496
-10,271
-87% -$1.19M ﹤0.01% 669
2018
Q3
$1.42M Sell
11,767
-152,308
-93% -$18.9M 0.01% 489
2018
Q2
$18.9M Sell
164,075
-71,329
-30% -$7.8M 0.07% 203
2018
Q1
$20.2M Buy
235,404
+185
+0.1% +$14.3K 0.08% 206
2017
Q4
$17.4M Buy
235,219
+139,643
+146% +$9.34M 0.07% 211
2017
Q3
$5.51M Buy
95,576
+11,969
+14% +$707K 0.02% 354
2017
Q2
$5.36M Buy
83,607
+49,917
+148% +$3.08M 0.02% 338
2017
Q1
$1.94M Buy
33,690
+14,514
+76% +$866K 0.01% 491
2016
Q4
$1.18M Buy
+19,176
New +$1.25M 0.01% 526

Other funds holding USNA

DZ Bank's USNA Position: Q1 2019 in Review

DZ Bank sold out of Usana Health Sciences (USNA) in Q1 2019, closing a stake of 1,496 shares — an estimated $171K sold.

DZ Bank first reported a position in USNA in Q4 2016 and held it in 9 quarters. The position peaked at $20.2M in Q1 2018. 188 funds tracked by Wall St. Rank hold USNA as of Q1 2019.

  • DZ Bank reported no remaining Usana Health Sciences position as of Q1 2019 after selling out during the quarter.
  • DZ Bank sold 1,496 Usana Health Sciences shares in Q1 2019, an estimated $171K.
  • DZ Bank first reported a position in Usana Health Sciences in Q4 2016 and held it in 9 quarters.
  • DZ Bank's Usana Health Sciences position peaked at $20.2M in Q1 2018.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2019.

Based on DZ Bank's 13F filing for Q1 2019, filed 15 May 2019.